2C-T-20
A synthetic psychedelic compound
2C-T-20 is a synthetic psychedelic compound belonging to the 2C family of phenethylamines. It was first synthesized by the chemist Alexander Shulgin and is documented in his book PiHKAL (Phenethylamines I Have Known And Loved).
Chemical Structure and Properties[edit | edit source]
2C-T-20 is chemically known as 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine. It is a member of the 2C-T series, which are characterized by the presence of a thioether group attached to the phenyl ring. The compound has a molecular formula of C13H21NO2S and a molecular weight of 255.37 g/mol.
Pharmacology[edit | edit source]
2C-T-20 acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. The compound is known to produce alterations in perception, mood, and cognition, similar to other psychedelics such as LSD and psilocybin.
Effects[edit | edit source]
The effects of 2C-T-20 can vary significantly depending on the dose, individual physiology, and set and setting. Common effects include:
- Visual and auditory hallucinations
- Altered sense of time and space
- Enhanced emotional experiences
- Increased introspection
The onset of effects typically occurs within 1 to 2 hours after ingestion, with the peak lasting 4 to 6 hours, and a gradual decline over the next few hours.
Safety and Toxicity[edit | edit source]
The safety profile of 2C-T-20 is not well-established due to limited research. As with many psychedelics, there is a potential for psychological distress, particularly in individuals with a predisposition to mental health disorders. Physical side effects may include nausea, increased heart rate, and hypertension.
Legal Status[edit | edit source]
2C-T-20 is not specifically scheduled under the Controlled Substances Act in the United States, but it may be considered an analogue of other controlled substances, making it potentially subject to prosecution under the Federal Analogue Act. Its legal status varies in other countries.
History and Research[edit | edit source]
2C-T-20 was first synthesized by Alexander Shulgin, who described it in PiHKAL. It has not been widely studied in scientific literature, and most information about its effects and safety comes from anecdotal reports.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD